Healthcare -
Biotechnology - NASDAQ - US
$ 0.9163
-12.7 %
$ 118 M
Market Cap
-0.29
P/E
HUMAW - COST OF REVENUE
Cost of Revenue HUMAW - Humacyte, Inc.
76.6 M
LAST VALUE
3852.52%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR